Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 243 followers
Latest posts
Last updated about 4 hours ago
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 45, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Nyxthracis (previously Obiltoxaximab SFL), obiltoxaximab, Date of authorisation: 18/11/2020, Revision: 3, Status: Withdrawn (authorisation)
about 4 hours ago
Human medicines European public assessment report (EPAR): Nyxthracis (previously Obiltoxaximab SFL), obiltoxaximab...
Scientific Symposium on Advanced Therapy Medicinal Products - ‘Contribution, evolution, revolution’, European Medicines Agency, Amsterdam, the Netherlands, from 10 October 2024, 09:00 (CEST) to 10 October 2024, 17:00 (CEST)
about 5 hours ago
Scientific Symposium on Advanced Therapy Medicinal Products - ‘Contribution, evolution, revolution’, European...
Info session on web-based electronic Application Form (eAF) add package, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 July 2024, 11:00 (CEST) to 18 July 2024, 12:00 (CEST)
about 5 hours ago
Info session on web-based electronic Application Form (eAF) add package, Online, European...
Questions and answers - Info session on web-based electronic Application Form (eAF) add package
about 5 hours ago
Questions and answers - Info session on web-based electronic Application Form (eAF)...
Member states contact points for translations review
about 5 hours ago
Member states contact points for translations review
Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation: 27/05/2024, Revision: 1, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation...
Agenda of the CVMP meeting 10-12 September 2024
about 6 hours ago
Agenda of the CVMP meeting 10-12 September 2024
Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Date of authorisation: 21/11/2014, Revision: 16, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Date of...
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
about 10 hours ago
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No...
Committee for Advanced Therapies (CAT): 11-12 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 11 September 2024 to 12 September 2024
about 10 hours ago
Committee for Advanced Therapies (CAT): 11-12 September 2024, European Medicines Agency, Amsterdam...
Clinical development of medicinal products for the treatment and prevention of bipolar disorder
about 12 hours ago
Clinical development of medicinal products for the treatment and prevention of bipolar...